Lysionotin nanoparticles ameliorate ethanol-elicited liver damage by inhibiting hepatocyte ferroptosis and modulating the gut-liver axis
- 16 February 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 174, 116383
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 75 references indexed in Scilit:
- Flavonoids in the treatment of alcohol‐related liver disease: evidence, molecular mechanisms, and challengesJournal of the Science of Food and Agriculture, 2026
- The SLCO4A1‐Mediated Transmembrane Transport of Lysionotin Attenuates Acute Lung Injury Through Activating the AMPK/Nrf2 Signaling PathwayPhytotherapy Research, 2025
- Akkermansia muciniphila and Alcohol‐Related Liver Diseases. A Systematic ReviewMolecular Nutrition & Food Research, 2023
- Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targetsCellular and Molecular Life Sciences, 2022
- Adipose‐Specific Lipin‐1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in MiceHepatology Communications, 2019
- M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver diseaseHepatology, 2013
- Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in miceHepatology, 2013
- Alcoholic Liver DiseaseHepatology, 2010
- Small bowel bacterial overgrowth in patients with alcoholic cirrhosisDigestive Diseases and Sciences, 1996
- Small bowel bacterial overgrowth in patients with alcoholic cirrhosisDigestive Diseases and Sciences, 1995